Your browser doesn't support javascript.
loading
A rare EGFR mutation L747P conferred therapeutic efficacy to both gefitinib and osimertinib: A case report.
Huang, Xiaojie; Yang, Yan; Wang, Pingli; Wang, Jia; Chen, Songan; Mao, Xinru; Ding, Liren.
  • Huang X; Department of Respiratory Medicine, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, 310052, Zhejiang, China.
  • Yang Y; Department of Respiratory Medicine, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, 310052, Zhejiang, China.
  • Wang P; Department of Respiratory Medicine, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, 310052, Zhejiang, China.
  • Wang J; Burning Rock Biotech, Guangzhou, China.
  • Chen S; Burning Rock Biotech, Guangzhou, China.
  • Mao X; Burning Rock Biotech, Guangzhou, China.
  • Ding L; Department of Respiratory Medicine, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, 310052, Zhejiang, China. Electronic address: lirending@zju.edu.cn.
Lung Cancer ; 150: 9-11, 2020 12.
Article en En | MEDLINE | ID: mdl-33035779
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptores ErbB / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptores ErbB / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article